Global Pharmaceutical Cartridges Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Material (Glass, Plastic), By Cartridge Size (Less Than 3 Ml, 3ml To 5ml, 5ml To 10ml, Greater Than 10ml), By End-User (Pharmaceutical Company, Biotech Company, Biomedical Research Organization), And By Geography- Forecasts From 2022 To 2027

The global pharmaceutical cartridge market is estimated to reach a market size of US$1.712 billion in 2027.

Owing to the growing demand for effective packaging solutions for preventing drug contamination, the pharmaceutical packaging cartridge market holds strong growth prospects in the forecast period. Thus, the growing pharmaceutical packaging industry is fueling the market demand. The growing chronic disease prevalence is driving market growth in the forecast period. With growing diabetes globally, insulin delivery systems using pre-fillable syringes are further augmenting the market demand. The growing geriatric population, accompanied by age-associated diseases, is further propelling the market demand in the forecast period. Moreover, cartridges form an important part of many drug delivery systems. Hence, with the growing drug delivery industry, the market is poised to grow at a significant pace. With the growing biomedical and biotech research worldwide, the use of cartridges is immense in biotech companies and biomedical research organizations apart from pharmaceutical organizations. Hence, these are further providing an opportunity for the market to thrive in the forecast period.

Geographically, the USA in the North American region is estimated to hold a significant market share with high expenditure and a well-established pharmaceutical industry here. On the other hand, Asia Pacific is projected to grow with a high CAGR, especially in the developing economies of India and China, owing to the high prevalence of people suffering from chronic diseases like diabetes and is insulin-dependent. 

The prevalence of insulin-dependent diabetes, type 1 and type 2, is augmenting the market demand in the forecast period.

According to the American Diabetes Association(ADA), the prevalence of individuals with type 1 diabetes where the pancreas is not capable of producing insulin is prevalent. More than one million Americans have this disease. Type 2 diabetes is the most common form of diabetes found in the United States, according to CDC, more than 90% of individuals are diagnosed with this disease. However, not everyone is recommended for insulin injections. In 2018, 34.2 million Americans were affected by diabetes, and around 1.6 million Americans were found to have type 1 diabetes, which included nearly 187,000 children and adolescents (source: ADA).

Hence, with the high disease prevalence, the market for insulin cartridges holds strong growth prospects in the United States and other parts of the world.

According to the WHO, in 2016, diabetes was the reason for 1.6 million deaths globally. Furthermore, the common consequences of diabetes include damage to the heart, blood vessels, kidneys, eyes, and nerves. Individuals suffering from diabetes are at an increased risk of heart attacks and strokes. With reduced blood flow, there are high chances of nerve damage in the feet, which raises the chances of foot ulcers and infection, resulting in limb amputation. Also, diabetic retinopathy plays an important role in causing blindness due to damage to small blood vessels in the retina. It is estimated that this contributes to around 2% of blindness at the global level. Hence, effective measures are taken for early disease diagnosis and prevention.  Also, in the case of severe diabetes requiring insulin drug delivery, the market is propelled to grow at a significant pace in the forecast period.

As per the International Diabetes Federation (IDF) Statistics, at present, every 7 seconds, a person is estimated to die from diabetes or diabetes-related complications, accounting for around 4 million deaths every year. Around half of all deaths are attributed to people under the age of 60.

The prevalence is estimated to increase to 9.9% by 2045 from a predicted prevalence of 8.8% of the total global population in 2017. In 2017, 424.9 million people were affected by diabetes globally, and this is projected to surge to 628.6 million individuals by the end of 2045.

The presence of companies offering varied products of different capacities as per the customers’ demand is driving the market growth in the forecast period.

Various drug delivery devices that make use of multi-use pens or pen injectors demand cartridge technology for safe drug storage and also hold suitability for high-viscosity drugs under various storage conditions.

West Pharmaceutical Services Daikyo Crystal Zenith® cartridges provide superior, predictable functionality, safety, and compatibility with varied devices. This comprises a crystal zenith polymer. Superior barrier protection, superior functional performance without silicone oil, compatibility with high-viscosity drugs, tight dimensional tolerances, and suitability for auto-injectors and pen-delivery systems are all features of these cartridges. The company’s SmartDose® Generation I drug delivery platform, approved by the US FDA, offers a wearable subcutaneous injector with an integrated drug delivery system for delivering a truly patient-centric approach to self-administration. The device is capable of user-loaded, subcutaneous self-administration is capable of introducing high volume and high viscosity drug products are connectivity capable, and easy and convenient to operate.

SCHOTT AG offers a broad range of containers, quality levels, and controlled surface chemistry for the fulfillment of the customized needs of primary packaging. Also, these comply with PH. Eur., USP, and JP international standards. Schott cartridges are manufactured based on advanced production lines containing highly stable and validated processes. Permanent process optimization is achieved through Six Sigma principles, in addition to the professional training provided to the employees, which contributes to maintaining the quality to the highest levels. The cartridge handling is continuously optimized to decrease glass-to-glass contact, thereby leading to an increase in mechanical strength and exceptional cosmetic quality.

Gerresheimer cartridges are high-quality cartridges with fill volumes that range from 1.5 ml to 3.0 ml. Also, up to 10 ml can be manufactured as per the customer’s need for various pharma applications. The product range consists of clear and amber cartridges that are made of borosilicate glass of hydrolytic class I. There are options for ammonium sulfate treatment for enhanced surface resistance. The company manufactures cartridges for dental applications and cartridges for pen drug delivery systems.

Recent Development and expansions

• The first generic version of APOKYN® Cartridges, apomorphine hydrochloride cartridges, 30 mg/3 mL, was approved and launched in March 2022 by TruPharma, LLC and its development and business partner Sage Chemical, Inc. 
• The international technology company SCHOTT announced in May 2022 that it would be greatly increasing the number of ready-to-use (RTU) cartridges it could produce. With the use of wearable technology or pen injectors, this drug containment & delivery solution is being used to store as well as dispense medications.

COVID-19 Impact on Pharmaceutical Cartridges Market

Due to the COVID-19 pandemic, the medical cartridges market is expanding slowly owing to the closure of plants that make medical cartridges as a result of the global lockdowns that were enacted. Pharmaceutical representatives were also unable to connect directly with healthcare professionals due to social restrictions on movement and other factors. Regulatory agencies have also temporarily ceased authorizing pharmaceutical items, and other clinical trials have also been put on hold.

Global Pharmaceutical Cartridges Market Scope:

Segmentation:

• By Material
  • Glass
  • Plastic
• By Cartridge Size
  • Less than 3ml
  • 3ml to 5ml
  • 5ml to 10ml
  • Greater than 10ml
• By End User
  • Pharmaceutical Company
  • Biotech Company
  • Biomedical Research Organization
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Others
  • Middle East and Africa
    • UAE
    • Israel
    • Saudi Arabia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Indonesia
    • Taiwan
    • Thailand
    • Others